INVAInnoviva, Inc.

$1B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$64M-4.4% YoY

Gross Profit

$64M100.0% margin

Operating Income

$60M93.2% margin

Net Income

$38M58.9% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

+16.2%

Cash Flow

Operating Cash Flow

$56M

Free Cash Flow

$56M

Stock-Based Comp.

$474,000

Balance Sheet

Total Assets

$642M

Total Liabilities

$396M

Stockholders' Equity

$227M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$67M	-4.4%
Gross Profit	$64M	$67M	-4.4%
Operating Income	$60M	$63M	-4.7%
Net Income	$38M	$55M	-30.9%

INVA Q2 2019 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena